INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

The present dislosure is directed to certain functionalized dual substitute arene derivatives joined by a cyclic or heterocyclic linker of Formula (I): and pharmaceutically acceptable salts thereof, wherein X1, X2, Y, Z, G1, G2, R1, R2, R3, and R4 are as defined herein, which are potent inhibitors of MsbA and may be useful in the treatment of infections caused by any multi-drug resistant (MDR) Gram-negative bacteria. The dislosure is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of infections in which MsbA is involved..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 23. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

RAHEEM IZZAT [VerfasserIn]
BALIBAR CARL J [VerfasserIn]
SKUDLAREK JASON W [VerfasserIn]
LABROLI MARC A [VerfasserIn]
MITCHELL HELEN [VerfasserIn]
TONG LING [VerfasserIn]
FORSTER ASHLEY [VerfasserIn]
WANG HAO [VerfasserIn]
WU CHENGWEI [VerfasserIn]
BUEVICH ALEXEI [VerfasserIn]
ZHANG LI-KANG [VerfasserIn]
LIU JIAN [VerfasserIn]
BABAOGLU KERIM [VerfasserIn]
WU ZHE [VerfasserIn]
SHAW ANTHONY W [VerfasserIn]
COOKE ANDREW J [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-23, Last update posted on www.tib.eu: 2024-01-03, Last updated: 2024-01-12

Patentnummer:

WO2023224892

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018743501